Author(s): Sheila Menon, Vidya Bhagat

Email(s): menonsheila@yahoo.com

DOI: 10.52711/0974-360X.2024.00148   

Address: Sheila Menon1*, Vidya Bhagat2
1London College of Clinical Hypnosis Asia, LCCH Asia, 807 Block B Phileo Damansara1,
Jalan Damansara, Section 16/11 Petaling Jaya Selangor 43650 Malaysia.
2A.J. Institute of Hospital Management, Mangalore Rajeev Gandhi University, Mangalore 2, India.
*Corresponding Author

Published In:   Volume - 17,      Issue - 2,     Year - 2024


ABSTRACT:
Hypnosis is emerging as a valuable therapeutic tool with significant potential for recognition and application across medical settings. Of particular note are the evidenced benefits when addressing pervasive challenges such as chronic pain, anxiety, and emotional distress, which are often exacerbated by medical procedures. However, despite its potential for wide utilization in medical contexts, recognition of hypnotherapy's efficacy remains slow and hypnosis is often a second choice, last resort or offered as an adjuvant or supporting role alongside other treatments. One reason is that hypnosis lacks a well-defined role within the healthcare system. This gap persists even as mounting evidence suggests that hypnosis offers the capacity to bring about relief and positive outcomes across diverse issues and populations. Author Sheila Menon, Principal and Administrator of a clinical hypnosis Training and Clinical Facility draws upon extensive experience in clinical intervention and administration to extract scientific values from empirically driven experiences and data. In this paper the RE-AIM Framework is utilised to explore the multifaceted potential of hypnosis in medical settings, shedding light on the need for a more clearly defined integration of this intervention into mainstream healthcare practices. The authors draw from the evidence to make a case that the time is right to recognise hypnosis as a stand-alone psychotherapy and that this will enhance its adoption, reach and efficacy. It is further suggested that rebranding or relabeling this intervention will remove unnecessary biases and make it easier to implement and maintain for the benefit of patients and to improve treatment outcomes. Purpose: the purpose of this study is to use the RE-AIM Framework to evaluate the existing research that consistently provides evidence for better inclusion of hypnosis and to identify new insights into how this useful treatment can be more easily adopted and utilized in the healthcare system based on its interventional strength. Methodology: This is a descriptive study based on secondary data collected from literature following a descriptive analysis. The RE-AIM Framework is used as a mechanism for evaluating hypnosis interventions and to establish a rationale for relabeling them as psychotherapy based on treatment outcomes, interventional strengths and its operative usage in the healthcare system The literature search extracts information from the electronic database to make the study more robust and the literature selected is drawn from those published in the past two decades using keywords such as hypnosis intervention, RE-AIM, hypnosis in health care, mental health, and hypnosis interventions in a medical setup. Conclusion: This study uses the RE-AIM to present a case for relabeling or rebranding hypnosis as a psychotherapy in its own right to enhance its adoption and reach within a wide range of healthcare settings. The research supports the interventional strength of hypnosis as ready for this form of evolution and suggests that the rebranding will encourage healthcare providers to use hypnosis as a primary treatment option rather than as an adjuvant or secondary treatment option. Best care practices will be advanced as a result and better adoption of hypnosis will encourage more research leading to enhanced efficacy and resulting in improved implementation models. The authors suggest that once hypnosis is relabeled as psychotherapy, its implementation becomes simple and cost-effective. The authors recommend rebranding hypnotherapy as Conscious–State Alteration Therapy to remove any residual biases associated with the name hypnosis (and to avoid the outdated practice of using it as a supporting therapy). They suggest that this process of rebranding follows the evolutionary wave that can occur within psychotherapy progression. The benefit is that the potential of hypnosis as a treatment option will be further extended into healthcare settings extending its use in the treatment of pain management, anxiety, stress, and emotional distress, expanding the benefits to a wider and more diverse group of patients and giving hypnosis a rightful place as a primary treatment option.


Cite this article:
Sheila Menon, Vidya Bhagat. Making a Case for Hypnosis: Using the RE-AIM Framework to Recognize Hypnosis as a Stand-Alone Therapeutic Intervention within Healthcare and Educational Systems. Research Journal of Pharmacy and Technology. 2024; 17(2):953-2. doi: 10.52711/0974-360X.2024.00148

Cite(Electronic):
Sheila Menon, Vidya Bhagat. Making a Case for Hypnosis: Using the RE-AIM Framework to Recognize Hypnosis as a Stand-Alone Therapeutic Intervention within Healthcare and Educational Systems. Research Journal of Pharmacy and Technology. 2024; 17(2):953-2. doi: 10.52711/0974-360X.2024.00148   Available on: https://rjptonline.org/AbstractView.aspx?PID=2024-17-2-76


REFERENCES:
1.    Fromm E. Significant developments in clinical hypnosis during the past 25 years. International Journal of Clinical and Experimental Hypnosis. 1987; 35(4): 215-30.
2.    Stewart JH. Hypnosis in contemporary medicine. In Mayo Clinic Proceedings.  2005; 80(4):  511-524.
3.    Rounsaville BJ, Carroll KM, Onken LS. A stage model of behavioral therapies research: Getting started and moving on from stage I. Clinical psychology: Science and Practice. 2001; 8(2):133.
4.    Ellis A. Early theories and practices of rational emotive behaviour therapy and how they have been augmented and revised during the last three decades. Advances in REBT: Theory, Practice, Research, Measurement, Prevention and Promotion. 2019:1-21.
5.    David D. Rational–emotive behavior therapy in the context of Modern Psychological Research. 2014.
6.    Seligman ME, Rashid T, Parks AC. Positive psychotherapy. American Psychologist. 2006;61(8):774.
7.    Aytaç D. Select ion of our books in exed i n the Book C i tat ion Index in Web of Science™ Core Co llection (B K CI) Interest ed in pub lishing with us? Cont act book. depar fitment@int echope n. com Num ers displayed above arebased on latest data collect ted. Spectrum; 154:6-300.
8.    Golden WL. Cognitive-behavioural hypnotherapy in the treatment of irritable bowel syndrome-induced agoraphobia. International Journal of Clinical and Experimental Hypnosis. 2007; 55(2):131-146
9.    Kirsch I, Montgomery G, Sapirstein G. Hypnosis as an adjunct to cognitive-behavioural psychotherapy: a meta-analysis. Journal of Consulting and Clinical Psychology. 1995; 63(2):214.
10.    Bryant R, Moulds M, Guthrie R, Nixon R. The additive benefit of hypnosis and cognitive–behavioural therapy in treating acute stress disorder. J. Consult. Clin. Psychol. 2005; 73, 334–340.
11.    Bryant R, Moulds M, Nixon R, Mastrodomenico J, Felmingham K, Hopwood S. Hypnotherapy and cognitive behaviour therapy of acute stress disorder: a 3-year follow-up. Behav. Res. Ther. 2006; 44(9): 1331–1335.
12.    Alladin A, Alibhai A. Cognitive hypnotherapy for depression: an empirical investigation. Int. J. Clin. Exp. Hypn. 2007; 55(2): 147–166 (2007).
13.    Schoenberger NE, Kirsch I, Gearan P et al. Hypnotic enhancement of a cognitive behavioural treatment for public speaking anxiety. Behav. Ther. 1997; 28(1): 127–140.
14.    Dgppn B, Kbv A, Akdä B, BApK DA, Degam D, DGPs DG. für die Leitliniengruppe Unipolare Depression. S3-Leitlinie/Nationale VersorgungsLeitlinie Unipolare Depression–Langfassung. 2009; 2:2020-02.
15.    Dgppn B, Kbv A, Akdä B, BApK DA, Degam D, DGPs DG. S3-Leitlinie/Nationale Versorgungs Leitlinie Unipolare Depression-Langfassung. Auflage. Version. 2015; 5:2015.
16.    National Institute for Health and Clinical Excellence. Depression: The Treatment and Management of Depression in Adults. British Psychological Society, 2010
17.    Hollon SD, DeRubeis RJ, Shelton RC, et al. Prevention of relapse following cognitive therapy vs. medications in moderate to severe depression. Arch Gen Psychiatry 2005; 62:417–22.
18.    Cause WD, Age S. by Country and by Region, 2000–2015. Geneva: World Health Organization. 2016.
19.    Luty SE, Carter JD, McKenzie JM, et al. Randomized controlled trial of interpersonal psychotherapy and cognitive-behavioral therapy for depression. Br J Psychiatry. 2007; 190:496–502.
20.    Young JE, Klosko JS, Weishaar ME. Schema therapy: A practitioner's guide: Guilford Press, 2003.
21.    Young JE, Mattila DE. Schema-focused therapy for depression. In: Reinecke MA, Davison MR, eds. Depression: A Practitioner's Guide to Comparative Treatments, New York: Springer. 2007: 9: 291–313.
22.    Greenberg LS, Watson JC. Emotion-focused therapy for depression. Washington: American Psychological Association, 2006.
23.    McCullough JP. Treatment for chronic depression: Cognitive behavioral analysis system of psychotherapy (CBASP). J Psych other Integr. 2003; 13:241–63.
24.    Teasdale JD, Segal ZV, Williams JMG, et al. Prevention of relapse/ recurrence in major depression by mindfulness-based cognitive therapy. J Consult Clin Psychol. 2000; 68:615–23.
25.    Hayes SC, Luoma JB, Bond FW, et al. Acceptance and commitment therapy: model, processes, and outcomes. Behav Res Ther. 2006; 44:1–25.
26.    Churchill R, Moore TH, Furukawa TA, et al. ‘Third wave' cognitive and behavioural therapies versus treatment as usual for depression. The Cochrane Library. 2013; 10:1–47.
27.    Revenstorf D, Peter B. Hypnose in Psychotherapie, Psychosomatik und Medizin (2. Aufl). Berlin: Springer, 2009.
28.    Alladin A. Evidence-based hypnotherapy for depression. Int J Clin Exp Hypn. 2010; 58:165–85.
29.    Alladin A. Cognitive hypnotherapy for major depressive disorder. Am J Clin Hypn. 2012; 54:275–93
30.    Alladin A. Cognitive hypnotherapy: a new vision and strategy for research and practice. Am J Clin Hypn. 2012; 54:249–62.
31.    Golden WL. Cognitive hypnotherapy for anxiety disorders. Am J Clin Hypn. 2012; 54:263–74.
32.    Kirsch I, Montgomery G, Sapirstein G. Hypnosis as an adjunct to cognitive-behavioral psychotherapy: a meta-analysis. J Consult Clin Psychol. 1995; 63:214–20.
33.    Dobson KS, Dozois DJ, editors. Handbook of cognitive-behavioral therapies. Guilford Publications; 2021.
34.    Beck AT, editor. Cognitive therapy of depression. Guilford Press; 1979.
35.    Cramer H, Lauche R, Paul A, Langhorst J, Kuemmel S, Dobos GJ. Hypnosis in breast cancer care: a systematic review of randomized controlled trials. Integrative Cancer Therapies. 2015; 14(1): 5-15.
36.    Jensen MP. Hypnosis for chronic pain management: Therapist guide. Oxford University Press; 2011.
37.    Alladin A. Cognitive hypnotherapy: An integrated approach to the treatment of emotional disorders. John Wiley & Sons; 2008 Apr 28.
38.    Jensen MP, Patterson DR. Hypnotic approaches for chronic pain management: clinical implications of recent research findings. American Psychologist. 2014; 69(2):167.
39.    Carona C. The philosophical assumptions across the ‘three waves’ of cognitive–behavioural therapy: how compatible are they? BJ Psych Advances. 2023; 29(3): 213-7.
40.    Glasgow RE, Harden SM, Gaglio B, Rabin B, Smith ML, Porter GC, Ory MG, Estabrooks PA. RE-AIM planning and evaluation framework: adapting to new science and practice with a 20-year review. Frontiers in Public Health. 2019; 7: 64.
41.    Glasgow RE, Vogt TM, Boles SM. Evaluating the public health impact of health promotion interventions: the RE-AIM framework. American Journal of Public Health. 1999; 89(9): 1322-7.
42.    Peter J, Fournier C, Keip B, Rittershaus N, Stephanou-Rieser N, Durdevic M, Dejaco C, Michalski M, Moser G. Intestinal microbiome in irritable bowel syndrome before and after gut-directed hypnotherapy. International Journal of Molecular Sciences. 2018; 19(11): 3619.



Recomonded Articles:

Research Journal of Pharmacy and Technology (RJPT) is an international, peer-reviewed, multidisciplinary journal.... Read more >>>

RNI: CHHENG00387/33/1/2008-TC                     
DOI: 10.5958/0974-360X 

1.3
2021CiteScore
 
56th percentile
Powered by  Scopus


SCImago Journal & Country Rank

Journal Policies & Information


Recent Articles




Tags


Not Available